跳至主要内容
临床试验/NCT06735924
NCT06735924进行中(未招募)不适用

Non Alcoholic Fatty Liver Disease and Endogenous Oxalate Synthesis

University of Alabama at Birmingham2 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2023年4月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
28
试验地点
2
主要终点
estimated endogenous oxalate synthesis rate

研究概览

简要总结

This study aims to determine the daily rate of endogenous synthesis of oxalate using fasted urine collection and a low-oxalate controlled diet in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

详细描述

Urinary oxalate excretion is derived from both dietary sources and endogenous synthesis. This study will use a low-oxalate controlled diet, repeat fasted urine collections and 24-hr urine collections on a low-oxalate diet, to determine the daily rate of endogenous oxalate synthesis in individuals with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age >18 years
  • History of MASLD, with liver fat content > 5%
  • Normal kidney function
  • Stable medication for at least 1 month for diabetes mellitus if any
  • Willingess to ingest fixed diets and stop dietary supplements for the study and come to UAB for visits

排除标准

  • Age < 18 years
  • Inaccurate 24-hour urine collections
  • Liver fat content <5%
  • Liver cirrhosis
  • Evidence of other chronic liver disease, viral hepatitis
  • history of alcoholism within 2 years of enrollment
  • Contra-indication to Magnetic Resonance Imaging
  • Chronic kidney disease with estimated Glomerular Filtration rate < 60 ml/min/1.73m2
  • Type 1 Diabetes Mellitus or treatment with insulin
  • Uncontrolled diabetes
  • Pregnancy, lactation or intention to be
  • Uncontrolled hypertension
  • Use of weight loss medication, SGLT2 inhibitors, GLP-1 receptor agonists, osteoporosis medication, chronic NSAID
  • History of gastric or intestinal surgery or resection that could potentially alter oxalate absorption
  • Chronic fat malabsorption
  • Use of immunosuppressive medications
  • Known immuno-compromised status
  • Active malignancy or treatment for malignanacy within the last 12 months

研究组 & 干预措施

Estimation of endogenous oxalate production

Experimental

Fasted hourly urine collections after equilibration on a low-oxalate diet

干预措施: Low-oxalate fixed diet (Dietary Supplement)

结局指标

主要结局

estimated endogenous oxalate synthesis rate

时间窗: 1 day

Average fasted hourly urinary oxalate excretion rate normalized to urinary creatinine excretion (mg oxalate / g urinary creatinine)

次要结局

  • Urinary Oxalate excretion(2 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kyle D. Wood

Principal Investigator

University of Alabama at Birmingham

研究点 (2)

Loading locations...

相似试验

Influence of Metabolic Syndrome on Endogenous... | 临床试验